August 14th 2025
Irina Mazur spoke to Dermatology Times about the latest partnership, which aims to bridge the gap between clinical advice and patient behavior through personalized sun protection guidance.
Immune response modifier post-op
July 1st 2006San Francisco - Results from several studies performed with imiquimod 5 percent cream (Aldara, 3M Pharmaceuticals) suggest that the immune response modifier may have a role as a surgical adjuvant for improving local tumor control and/or to enhance scar appearance, says James M. Spencer, M.D., M.S., clinical professor of dermatology, Mt. Sinai School of Medicine, New York.
Take conservative approach to enjoy CO2 's plentiful benefits
July 1st 2006Scottsdale, Ariz. - Although it remains the gold standard for skin rejuvenation, CO2 laser resurfacing is paradoxically losing favor due to drawbacks ranging from the risk of complications to increasing patient reluctance over downtime and concerns about the complications.
Juvederm approval broadens filler options
July 1st 2006Irvine, Calif. - The Food and Drug Administration 's approval of the Juvederm gel (hyaluronic acid/HA, Allergan) product family could threaten Restylane's (Medicis) dominance of the dermal filler category while expanding the facial aesthetic marketplace, sources tell Dermatology Times.
Studies demonstrate safety, efficacy of CaHA for facial lipoatrophy
July 1st 2006National report - Results of two parallel, prospective, open-label, North American studies demonstrate that treatment with the injectable filler consisting of microspheres of calcium hydroxylapatite (CaHA) in a carboxymethylcellulose gel carrier (Radiesse, BioForm Medical) provides safe, immediate and relatively durable restoration of facial volume in patients with HIV-associated lipoatrophy.
Immune response modifier post-op
July 1st 2006San Francisco - Results from several studies performed with imiquimod 5 percent cream (Aldara, 3M Pharmaceuticals) suggest that the immune response modifier may have a role as a surgical adjuvant for improving local tumor control and/or to enhance scar appearance, says James M. Spencer, M.D., M.S., clinical professor of dermatology, Mt. Sinai School of Medicine, New York.
DT senior editor published in JAMA
July 1st 2006Cleveland - "At Face Value," written by Dermatology Times Senior Editor Karen Donley-Hayes, appeared in the June 21, 2006, issue of the Journal of the American Medical Association (JAMA, Vol.295, No. 23, 2701-2702). A story spurred by the essay was also published on Heathday.com, and Ms. Donley-Hayes was interviewed for the University of Kentucky's Dr. Greg Davis on Medicine program, which aired on WUKY 91.3 FM UK Public Radio.
Treating the mosaic of Asian skin
June 1st 2006Rancho Mirage, Calif. - The Asian population has a spectrumof skin types, from the porcelain white of the Japanese to thebrowner Pacific Islanders, according to Wendy E. Roberts, M.D. Sheis a dermatologist here, and assistant clinical professor ofmedicine at Loma Linda University Medical School, Loma Linda,Calif.